Improvements in the Long-Term Outcome of Crohn's Disease Over the Past Two Decades and the Relation to Changes in Medical Management: Results from the Population-Based IBDSL Cohort. [electronic resource]
- The American journal of gastroenterology 02 2017
- 325-336 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1572-0241
10.1038/ajg.2016.524 doi
Adalimumab--therapeutic use Adult Antirheumatic Agents--therapeutic use Azathioprine--therapeutic use Biological Products--therapeutic use Crohn Disease--therapy Digestive System Surgical Procedures--trends Female Glucocorticoids--therapeutic use Hospitalization--trends Humans Immunologic Factors--therapeutic use Infliximab--therapeutic use Kaplan-Meier Estimate Male Mercaptopurine--therapeutic use Methotrexate--therapeutic use Middle Aged Multivariate Analysis Netherlands Prednisone--therapeutic use Propensity Score Proportional Hazards Models Severity of Illness Index Young Adult